Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 2

1(20.0%)

Phase 3

1(20.0%)

5Total

N/A(3)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT02245321Not ApplicableCompleted

Strategies to Reduce Iron Deficiency

Role: collaborator

NCT03907995Not ApplicableCompleted

Peer-led Group Intervention for Coping With Disaster

Role: collaborator

NCT02305732Completed

A Prospective, Open Label, Treatment Use Study of Patient Safety Following Transfusion of INTERCEPT Platelet Components

Role: collaborator

NCT01528449Phase 3Completed

Babesia Testing in Blood Donors

Role: collaborator

NCT01555060Phase 2Completed

Hemoglobin and Iron Recovery Study

Role: collaborator

NCT01226173Completed

Dengue Virus NS1 Antigen (Bio-Rad) Clinical Protocol

Role: collaborator

NCT00001999Not ApplicableCompleted

A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS

Role: lead

All 7 trials loaded